🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)The sulfur burps are KILLING me someone help Page 3

The sulfur burps are KILLING me someone help

NauseaFreeNow Thu, Apr 9, 2026 at 8:14 AM 27 replies 1,164 viewsPage 3 of 6
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Apr 10, 2026 at 3:00 PM#11
TinaHashiRN said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

30 5SallyK_inj, CryptoCarl, MariaRD and 27 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Apr 11, 2026 at 4:54 PM#12
LondonLisa said:
Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything.

Saving this. It is the first explanation that did not require me to already understand it.

29 4wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 26 others
Reply Quote Save Share Report
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Apr 12, 2026 at 6:49 PM#13
TinaHashiRN said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Correct me if the detail matters more than I have assumed.

28 3patPC_UT, Dr.DermMIA, fiona_VT and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Apr 13, 2026 at 8:44 PM#14

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

27 2Dr.PulmRoch, maya_sedona, stefan_berlin and 24 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 14, 2026 at 10:40 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Carry on.

Last edited: Apr 15, 2026 at 2:40 AM
26 1PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 23 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register